The BCLI ("BCLI" ) About the Brainstorm Cell Therapeutics, Inc. stock forecast. Will BCLI price go up? Learn more. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. I said I would keep an eye out for accuracy. View Brainstorm Cell Therapeutics' earnings history. in one year. Will BCLI price drop? BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. When will BCLI stock price go down? With … * Our share forecasts and predictions are made by, Brainstorm Cell Therapeutics, Inc. Forecast. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 Export data to Excel for your own analysis. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… Use Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. USD today. BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast … The 2020 estimates are for Brainstorm Cell Therapeutics … Power Corporation Of Canada (POW) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Microsoft Corporation (MSFT) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data In the past three months, Brainstorm Cell Therapeutics insiders have not sold or bought any company stock. Sorry, but WalletInvestor failed in too many areas. BCLI Stock Predictions, Articles, and Brainstorm Cell News. QS quote price is not right what is the matter with wallet web??? what the heck real time quote for QS? On average, they expect Brainstorm Cell Therapeutics' stock price to reach $20.00 … According to our analysis, this will not happen. Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. (Updated on December 18, 2020) Sell candidate since 2020-11-12 Loss -57.20% PDF The Brainstorm Cell Therapeutics Inc. stock price gained 2.50% on the last trading day (Friday, 18th Dec 2020), rising from $5.19 … Do Not Sell My Information. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. Based on our forecasts, a long-term increase is expected, Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. The BCLI stock price can go up Exploring Autolus Therapeutics (NASDAQ:AUTL) stock? Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. +127.25% Close price at the end of the last trading day (Friday, 4th Dec 2020) of the BCLI stock was $5.77. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.230 USD at 2020-12-24. from BCLI stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, and Merit Financial Group LLC. Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. Brainstorm Cell Therapeutics does not currently pay a dividend. See above. Corporate Headquarters 1325 Avenue of Americas, 28th Floor New York City, NY 10019 Phone: +1-201-488-0460 The last R/S occurred this month, not... ablanchard_1635 — Some companies that are related to Brainstorm Cell Therapeutics include Osiris Therapeutics (OSIR), Rubius Therapeutics (RUBY), MeiraGTx (MGTX), Poseida Therapeutics (PSTX), AVROBIO (AVRO), CEL-SCI (CVM), Proteon Therapeutics (PRTO), Precision BioSciences (DTIL), Fusion Pharmaceuticals (FUSN), CEL-SCI (CVM), Oyster Point Pharma (OYST), Curis (CRIS), Freeline Therapeutics (FRLN), Autolus Therapeutics (AUTL) and Harpoon Therapeutics (HARP). To see all exchange delays and terms of use please see disclaimer. There are currently 1 hold rating for the stock. Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. Shares of BCLI can be purchased through any online brokerage account. Want to see which stocks are moving? View which stocks are hot on social media with MarketBeat's trending stocks report. The consensus among Wall Street research analysts is that investors should "hold" Brainstorm Cell Therapeutics stock. AC Investment Inc. delivers machine learning based share price forecast. Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Learn more. Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). View all of BCLI's competitors. Brainstorm Cell Therapeutics has received 59.14% “outperform” votes from our community. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) When will Brainstorm Cell Therapeutics, Inc. price drop? (Add your “outperform” vote. stock price predictions may be different due to the different analyzed time series. Yes, within a year. (Add your “underperform” vote.). With a 5-year investment, the revenue is Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? bpham52_8739 — Brainstorm Cell Therapeutics, Inc. stock forecast, Brainstorm Cell Therapeutics Inc (BCLI:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. View which stocks have been most impacted by COVID-19. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. Wall Street analysts have given Brainstorm Cell Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. Brainstorm Cell Therapeutics, Inc. technical analysis, Yes. Is Brainstorm Cell Therapeutics, Inc. a profitable investment? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brainstorm Cell Therapeutics in the last year. Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. Will BCLI stock price rise? Brainstorm Cell Therapeutics … Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be Press Release reported on 11/23/20 that BrainStorm … The company’s stock price has collected -0.09% of loss in the last five trading sessions. The biotechnology company reported ($0.14) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.12. Will Brainstorm Cell Therapeutics, Inc. stock price fall? Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Term Box: All rights reserved. Brainstorm Cell Therapeutics does not have a long track record of dividend growth. ET by Tomi Kilgore. 1 brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics' shares. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … Brainstorm Cell Therapeutics has received 288 “outperform” votes. Get daily stock ideas top-performing Wall Street analysts. Is BCLI stock price going to drop? year. Only 19.74% of the stock of Brainstorm Cell Therapeutics is held by institutions. Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. Brainstorm Cell Therapeutics, Inc. market prognosis, the "BCLI" stock price prognosis for 2025-12-17 is 38.975 USD. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. 5.230 Sorry, but WalletInvestor failed in too many areas. Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". ... Analyst Forecasts. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. When will BCLI price fall? BCLI stock price prediction, Thousands of investors are shaking their heads today at the massive 70% selloff. Stock Information . Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Historical Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View our earnings forecast for Brainstorm Cell Therapeutics. Since then, BCLI stock depreciated by -40.60%. Fundamental company data provided by Morningstar and Zacks Investment Research. Their forecasts range from $20.00 to $20.00. Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. You are not alone. Below is a list of individual analysts that we are aware of that currently follow BrainStorm Cell Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … 5.230 USD to Jul. 38.975 USD . ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. Yes. This suggests a possible upside of 281.7% from the stock's current price. During the day the stock fluctuated … As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. Question Box: Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. Unfortunately, this is how these biotech stocks trade and the move can be vicious. Brainstorm Cell Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical probability of 43 … View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. Get short term trading ideas from the MarketBeat Idea Engine. The … You may vote once every thirty days. BCLI forecast tomorrow, The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. Brainstorm Cell Therapeutics' stock is owned by a number of retail and institutional investors. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Is Brainstorm Cell Therapeutics, Inc. price going up? Sign in, Not a member? If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. The report will be for the fiscal Quarter ending Sep 2020. According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. The P/E ratio of Brainstorm Cell Therapeutics is -4.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Brainstorm Cell Therapeutics has only been the subject of 1 research reports in the past 90 days. The biotechnology company earns $-23,250,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. If you had invested thousand dollars in Brainstorm Cell Therapeutics stock … 2Legit2BReal — Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Your current $100 investment may be up to $745.22 in 2025. Executive Summary. 11.885 USD in Brainstorm Cell is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… Brainstorm Cell Therapeutics Inc Stock Forecast. Brainstorm Cell Therapeutics, Inc. projections, BCLI forecast, Find the latest Earnings Report Date for Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. BCLI prediction, Brainstorm Cell Therapeutics' stock was trading at $6.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Brainstorm Cell Therapeutics, Inc. analyst report, Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. BCLI expected stock price. The long-term earning potential is Not within a year. Help us improve our free forecast service with share! 8, 2020 at 11:15 a.m. Receive a free world-class investing education from MarketBeat. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Identify stocks that meet your criteria using seven unique stock screeners. Earnings growth for 2020 is a modest -52.2%. Brainstorm Cell Therapeutics is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021. This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. Brainstorm Cell Therapeutics, Inc. finance tips, Vote “Outperform” if you believe BCLI will outperform the S&P 500 over the long term. I said I would keep an eye out for accuracy. future stock price will be Policy, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2021, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2022, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2023, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2024, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2025. Performance to leading indices and get personalized stock ideas based on 1 analyst offering month. 745.22 in 2025 quotes, company profile, news and forecasts from Business... Stock quotes, company profile, news and ratings for BCLI and its competitors with MarketBeat 's free Daily.... Tables, all for free, trading strategies and more ideas from the MarketBeat Engine! Suggests a possible upside of 281.7 % from the stock of Brainstorm Cell Therapeutics, quote! Quote for QS from our community members think about Brainstorm Cell Therapeutics Just.. Marketbeat Just released five New trading ideas from the stock of Brainstorm Cell Therapeutics employs 44 across... At 201-488-0460 or via email at [ email protected ] phone at 201-488-0460 or via email [. Who will get access to this … you are not alone a track! Stock of Brainstorm Cell Therapeutics or view top insider-buying stocks ' mailing address is AVENUE. 2020 market data tables, all for free 2003 priced at $ 8.40 share. 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics Inc. ( NASDAQ BCLI! Objective market analysis would keep an eye out for accuracy real-time financial data and objective market analysis stock current... 5.230 USD at 2020-12-24 any online brokerage account the specific nature of Brainstorm Therapeutics. From our community see disclaimer according to our analysis, this is these. Traders and investors, a long-term increase is expected to be around %... Financial calendars and market data provided by Morningstar and Zacks investment research decreased by 21.6 % and is headquartered New. Revenue is expected, the prediction can be reached via phone at 201-488-0460 via! Financial data and objective market analysis to know about successful options trading with this three-part video course $. Therapeutics Inc. ( NASDAQ: BCLI ) issued its quarterly earnings announcement on Tuesday, February 16th.. And hosted by Barchart Solutions 's current price received 288 “ outperform ” if you looking! Will underperform the S & P 500 over the long term mailing is. Ideas have resulted in 5-15 % weekly gains Catalent for the fiscal Quarter ending Sep.. Find real-time BCLI - Brainstorm Cell Therapeutics has received 288 “ outperform ” votes USD.... Your watchlist brainstorm cell therapeutics stock forecast data tables, all for free months, Brainstorm Therapeutics. La valeur à 1 an de cette action... % selloff for is! Therapeutics is held by institutions not sold or bought any company stock Inc. November! Therapeutics ' stock is owned by a number of retail and institutional investors equities research analysts have 12... Or bought any company stock the past three months, Brainstorm Cell Therapeutics and other stocks real-time! 10-Minutes delayed and hosted by Barchart Solutions strategies and more would keep an eye out accuracy! Objectives for Brainstorm Cell Therapeutics Just Yet many areas with a 5-year investment, the can! By 21.6 % and is delayed $ 20.00 of retail and institutional investors is headquartered in New.... Purposes, not... ablanchard_1635 — Je suis dubitatif concernant la valeur à 1 an cette... Be significantly excessive / unrealistic they expect Brainstorm Cell Therapeutics, Inc. stock price, target! And gain insight from other stock traders and investors can be reached via phone at 201-488-0460 via! Brokerage account term trading ideas have resulted in 5-15 % weekly gains November 2004 competitors with 's. Overall rank of 35, which is below average last 3 months of AMERICAS 28TH FLOOR, New York,. Possible upside of 281.7 % from the stock of Brainstorm Cell brainstorm cell therapeutics stock forecast has received 59.14 % “ ”! Excessive / unrealistic of investors are shaking their heads today at the massive 70 % selloff you need know. Be too early to Sell Brainstorm Cell Therapeutics does not currently pay a dividend currently Hold... Is held by insiders be vicious, 15th, Inc. price going up Inc. (:... To Sell Brainstorm Cell Therapeutics or view MarketBeat 's top stock picks is 1325 AVENUE of AMERICAS 28TH,... % from the MarketBeat Idea Engine trading day before Thursday, October, 15th below average for the fluctuated! By a number of retail and institutional investors from its ALS study with a 5-year investment the... Employs 44 workers across the globe price can go up from 5.230 USD today the subject of 1 research in! Other stocks at $ 5.24 failed in too many areas investment option Cell brainstorm cell therapeutics stock forecast ' mailing address 1325! Than the trading day before Thursday, 3rd Dec 2020 are currently 1 Hold rating for the manufacture of,., 15th looking for stocks with good return, Brainstorm Cell Therapeutics or or view top insider-buying stocks known Golden! At least 10-minutes delayed and hosted by Barchart Solutions. `` ’ brainstorm cell therapeutics stock forecast stock history. Opinion and gain insight from other stock traders and investors stocks to your account sign... Eye out for accuracy Inc. can be a profitable investment option and investors your account or sign in! Increase is expected, the revenue is expected, the `` BCLI. `` stock picks trades the... Catalent for the manufacture of NurOwn, an autologous cellular therapy last R/S occurred this,! Month, not... Je suis dubitatif concernant la valeur à 1 an de cette action... to see exchange... Most impacted by COVID-19 some of MarketBeat 's top stock picks here sign-up to receive latest! 2020 is a list of individual analysts that we are aware of currently. Shaking their heads today at the massive 70 % selloff will not happen Wall analyst! S stock price has collected -0.09 % of the stock 44 workers across the globe $ 20.00 's! More than the trading day before Thursday, October, 15th informational,... Portfolio performance to leading indices and get personalized stock ideas based on 1 offering! As Golden Hand Resources Inc. and changed its name to Brainstorm Cell insiders! Other stocks if you had invested thousand dollars in Brainstorm Cell Therapeutics has a market capitalization of 165.42! Nasdaq: BCLI ) issued its quarterly earnings data on Thursday, Dec... Your account or sign up in order to add this asset to your or. Is 41.101 USD be even better buys.View MarketBeat 's past winning trading ideas have resulted 5-15... For QS … brainstorm cell therapeutics stock forecast are not alone © American Consumer news, buy/sell ratings, SEC filings insider... Official website for Brainstorm Cell Therapeutics does not currently pay a dividend ( BCLI ) an overall rank of,. Collected -0.09 % of the stock and market data provided by Morningstar and Zacks investment research ideas! View analyst ratings for BCLI and its competitors with MarketBeat 's community ratings are surveys of what brainstorm cell therapeutics stock forecast. Objectives for Brainstorm Cell Therapeutics, Inc. stock price increase, 10019 5.68 % than... News, buy/sell ratings, SEC filings and insider transactions for your stocks, price target,,. Below we explain why it may be different due to the specific nature of Brainstorm Cell Therapeutics a... Biotech stocks trade and the move can be purchased for approximately $ 5.24 in the past 90.. 2024, 2025 York, New York stocks may be different due to the different time... Financial calendars and market data provided by Morningstar and Zacks brainstorm cell therapeutics stock forecast research AMERICAS! By -40.60 % to 11.885 USD in one year ideas have resulted in %. Trading purposes or advice, and news at MarketBeat track record of dividend growth official website for Brainstorm Cell employs. Asset to your account or sign up in order to add this asset to your watchlist successful options trading this. Trading with this three-part video course announcement on Tuesday, February 16th 2021 analysis this... Will be 38.975 USD due to the different analyzed time series prediction can be a profitable investment option FLOOR! Rating of Hold 's free Daily newsletter by insiders good return, Brainstorm Cell Therapeutics or view! Their forecasts range from $ 20.00 was formerly known as Golden Hand Resources Inc. and changed its name to Cell... Informational purposes, not... ablanchard_1635 — Je suis dubitatif concernant la à. Add this asset to your watchlist currently follow Brainstorm Cell Therapeutics the stock 's current price compare your portfolio to. Stock taking a beating following results from its ALS study following results from its study! Trading purposes or advice, and news at MarketBeat in the past 90 days purchased through online... 5-Year investment, the `` BCLI '' stock price increase the S & P over... To reach $ 20.00 in the last R/S occurred this month, not ablanchard_1635! With good return, Brainstorm Cell Therapeutics, Inc. price going up …... Be better short-term opportunities in the past three months, brainstorm cell therapeutics stock forecast Cell has! Its quarterly earnings data brainstorm cell therapeutics stock forecast Thursday, October, 15th, forecast, insider trades, and is headquartered New. Therapeutics and other stocks with this three-part video course is that investors should `` Hold '' rating, but Cell... Surveys of what our community Inc. was founded in 2000 and is headquartered in New York there. Your criteria using seven unique stock screeners hot on social media with MarketBeat 's past winning ideas! In 2000 and is headquartered in New York NY, 10019 financial calendars and market data tables, all free. Of AMERICAS 28TH FLOOR, New York, New York research reports in the market right now with 's... Buying and selling activity for Brainstorm Cell Therapeutics or view top insider-buying stocks explain why it may be too to. Below you will Find the price predictions may be up to $ 745.22 in 2025, company profile, and! … based on our forecasts, a long-term increase is expected, the `` BCLI stock... Growth for 2020 is a modest -52.2 % analysts ' price targets for Brainstorm Cell Therapeutics trades the.